PECAM1 and neoplasm: Interestingly, after TCN→PAC treatment of the Zfp217 overexpressing tumors, not only does the overall survival of the cohort increase for the animals with Zfp217 overexpressing tumors, but also the tumor burden decreases while the vessels of these tumors revert to primarily CD31+SMA+ vessels.